Cite Filings / AGMB
Feed Companies Filings Check
Sign in

CIK 0002020932

  • Non-accelerated filer
  • Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
Other
Phone
+32 33023530
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
Filings Financials Insiders Search text
All 52 Insider Trading 23 Beneficial Ownership Interest 7 Public Offerings 1 Foreign Private Issuers 14 Others 7
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-15
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-15
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-06
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-04-16
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-03-06
  8. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-02-17

Page 1 of 1 · 7 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…